Publications, Pharmaceutical

In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from a Nasal Spray and a Nasal Powder

There is growing recognition that targeted nasal deposition can help to realize the full potential of the nasal route for systemic and nose-to-brain drug delivery. This article describes an experimental study in which gamma scintigraphy was used to compare regional nasal deposition behavior for a nasal spray and nasal powder, with in vitro and in vivo studies. In vitro studies were carried out with a validated nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours). In vivo data was gathered from six healthy volunteers. Both sets of results indicate higher deposition in the olfactory region with the nasal powder. Agreement between in vitro and in vivo results highlights the potential to accelerate nasal drug development studies using appropriate in vitro test methods and nasal casts.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

4 Apr 2022

Why it is time to think differently about Nasal delivery of Biologics

Publications, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions

Read More
25 Feb 2022

Aptar Pharma discusses intranasal administration for CNS therapeutics

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
15 Feb 2022

New solutions for pre-clinical discovery in respiratory healthcare

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
28 Jan 2022

Improving Intranasal Sprays for Respiratory Viral Infections

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 12 13 14 15 16 25
Back To Top